These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 15916449)

  • 1. Traditional and newer therapeutic options for psoriatic arthritis: an evidence-based review.
    Gladman DD
    Drugs; 2005; 65(9):1223-38. PubMed ID: 15916449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistant cases of psoriatic arthritis: how to manage them.
    Atzeni F; Sarzi-Puttini P; Vena GA
    J Rheumatol Suppl; 2009 Aug; 83():73-5. PubMed ID: 19661549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of psoriatic arthritis therapies.
    Gladman DD
    Semin Arthritis Rheum; 2003 Aug; 33(1):29-37. PubMed ID: 12920694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-modifying antirheumatic drug therapy for psoriatic arthritis.
    Salvarani C; Cantini F; Olivieri I
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S71-5. PubMed ID: 12463452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Therapeutics in Psoriatic Arthritis. What Is in the Pipeline?
    Elalouf O; Chandran V
    Curr Rheumatol Rep; 2018 May; 20(7):36. PubMed ID: 29846825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [[WHAT SHOULD BE KNOWN ABOUT PSORIATIC ARTHRITIS]?].
    Kehler T; Čabrijan L
    Acta Med Croatica; 2015; 69(2):111-5. PubMed ID: 29076711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
    Pomerantz RG; Mody E; Husni ME; Qureshi AA
    J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.
    Elyoussfi S; Thomas BJ; Ciurtin C
    Rheumatol Int; 2016 May; 36(5):603-12. PubMed ID: 26892034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drugs for peripheral joint psoriatic arthritis.
    Drug Ther Bull; 2006 Jan; 44(1):1-5. PubMed ID: 16425898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of psoriatic arthritis among cutaneous psoriasis patients: from pathogenesis to therapy.
    Hoelt P; Confavreux C; Jullien D; Villani AP
    G Ital Dermatol Venereol; 2017 Oct; 152(5):458-473. PubMed ID: 28534601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Golimumab for the treatment of psoriatic arthritis.
    Yang H; Epstein D; Bojke L; Craig D; Light K; Bruce I; Sculpher M; Woolacott N
    Health Technol Assess; 2011 May; 15 Suppl 1():87-95. PubMed ID: 21609657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts and new developments in the treatment of psoriatic arthritis.
    Pipitone N; Kingsley GH; Manzo A; Scott DL; Pitzalis C
    Rheumatology (Oxford); 2003 Oct; 42(10):1138-48. PubMed ID: 12810935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review.
    Acosta Felquer ML; Coates LC; Soriano ER; Ranza R; Espinoza LR; Helliwell PS; FitzGerald O; McHugh N; Roussou E; Mease PJ
    J Rheumatol; 2014 Nov; 41(11):2277-85. PubMed ID: 25362711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing and treating psoriatic arthritis: an update.
    Boehncke WH; Qureshi A; Merola JF; Thaçi D; Krueger GG; Walsh J; Kim N; Gottlieb AB
    Br J Dermatol; 2014 Apr; 170(4):772-86. PubMed ID: 24266754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The actual role of therapy with traditional disease-modifying antirheumatic drugs in psoriatic arthritis.
    Soriano ER
    J Rheumatol Suppl; 2012 Jul; 89():67-70. PubMed ID: 22751597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs.
    Lubrano E; Scarpa R
    Reumatismo; 2012 Jun; 64(2):107-12. PubMed ID: 22690387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.
    Channual J; Wu JJ; Dann FJ
    Dermatol Ther; 2009; 22(1):61-73. PubMed ID: 19222518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Tumor Necrosis Factor-α Blockers in Psoriatic Disease. Therapeutic Options in Psoriatic Arthritis.
    Addimanda O; Possemato N; Caruso A; Pipitone N; Salvarani C
    J Rheumatol Suppl; 2015 Nov; 93():73-8. PubMed ID: 26523063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic therapy of psoriatic arthritis.
    Gladman DD
    Reumatismo; 2007; 59 Suppl 1():85-7. PubMed ID: 17828353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.